002393.SZ · 力生制药
China A-shares · RS rating 24 · As of 2026-10-14
| Price | 13.98 CNY |
|---|---|
| 1-day change | -0.1% |
| RS rating (overall / 1M / 3M / 12M) | 24 / 77 / 46 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 14 / 30 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -6.9% |
| Distance from 52-week high | +42.4% |
| Market cap (USD) | $657.0M |